REQUEST A DEMO
Total
USD $0.00
Search more companies

Przedsiebiorstwo Farmaceutyczne Sulphur Zdroj Exim Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Przedsiebiorstwo Farmaceutyczne Sulphur Zdroj Exim Sp. z o.o. Profile Updated: February 09, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Przedsiebiorstwo Farmaceutyczne Sulphur Zdroj Exim Sp. z o.o. is based in Poland, with the head office in Busko-Zdroj. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. It was first established on July 01, 2019. From the latest financial highlights, Przedsiebiorstwo Farmaceutyczne Sulphur Zdroj Exim Sp. z o.o. reported a net sales revenue increase of 15.72% in 2023. There was a total growth of 20.75% in Przedsiebiorstwo Farmaceutyczne Sulphur Zdroj Exim Sp. z o.o.’s total assets over the same period. In 2023, Przedsiebiorstwo Farmaceutyczne Sulphur Zdroj Exim Sp. z o.o.’s net profit margin decreased by 3.47%.

Headquarters
Ul. Bohaterow Warszawy 116A
Busko-Zdroj; Swietokrzyskie; Postal Code: 28-100

Contact Details: Purchase the Przedsiebiorstwo Farmaceutyczne Sulphur Zdroj Exim Sp. z o.o. report to view the information.

Website: http://www.sulphur.com.pl

Basic Information
Outstanding Shares:
Purchase the Przedsiebiorstwo Farmaceutyczne Sulphur Zdroj Exim Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Przedsiebiorstwo Farmaceutyczne Sulphur Zdroj Exim Sp. z o.o. report to view the information.
Incorporation Date:
July 01, 2019
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Przedsiebiorstwo Farmaceutyczne Sulphur Zdroj Exim Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
15.72%
Total operating revenue
14.78%
Operating profit (EBIT)
-14.73%
EBITDA
-16.54%
Net Profit (Loss) for the Period
-18.58%
Total assets
20.75%
Total equity
19.33%
Operating Profit Margin (ROS)
-3.27%
Net Profit Margin
-3.47%
Return on Equity (ROE)
-7.54%
Quick Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?